31 March 2021
India’s temporary hold on exports of AstraZeneca’s Covid-19 vaccine manufactured by the Serum Institute of India has affected South Korea -- which produces doses under COVAX for Malaysia -- amid production delays at a South Korean vaccine manufacturing plant.